Peptide affinity chromatography of human clotting factor VIII Screening of the vWF-binding domain
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-09-11
著者
-
Schwinn H
Octapharma Pharmazeutika Produktionsges. M. B. H.
-
NECINA Roman
Institute of Applied Microbiology, University of Agriculture
-
AMATSCHEK Karin
Institute of Applied Microbiology, University of Agriculture
-
SCHALLAUN Eva
Institute of Applied Microbiology, University of Agriculture
-
SCHWINN Horst
Octapharma Pharmazeutika Produktionsges. m. b. H.
-
JOSIC Djuro
Octapharma Pharmazeutika Produktionsges. m. b. H.
-
JUNGBAUER Alois
Institute of Applied Microbiology, University of Agriculture
-
Josic D
Octapharma Pharmazeutika Produktionsges M.b.h.
-
Josic Djuro
Octapharma Oberlaaer Strasse 235
-
Necina Roman
Institute Of Applied Microbiology University Of Agriculture
-
Schallaun Eva
Institute Of Applied Microbiology University Of Agriculture Forestry And Biotechnology
-
Schwinn Horst
Octapharma Pharmazeutika Produktionsges M.b.h. Research And Development And Virological Research Gro
-
Jungbauer A
Institute Of Applied Microbiology University Of Agriculture Forestry And Biotechnology
-
Jungbauer Alois
Institute For Applied Microbiology University Of Agricultural Sciences
-
Amatschek Karin
Institute Of Applied Microbiology University Of Agriculture
関連論文
- Peptide affinity chromatography of human clotting factor VIII Screening of the vWF-binding domain
- Analysis of protein aggregates by combination of cross-linking reactions and chromatographic separations
- Quantification of plasma-derived blood coagulation factor VIII by real-time biosensor measurements
- Issues in the development of medical products based on human plasma
- Whey proteins as a model system for chromatographic separation of proteins
- Comparison of protein A affinity sorbents
- Hydrophobic interaction chromatography of proteins II. Binding capacity, recovery and mass transfer properties
- Application of semi-industrial monolithic columns for downstream processing of clotting factor IX
- Laboratory-scale production and purification of recombinant HIV-1 reverse transcriptase
- Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion
- Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor Protein C
- 262 タンパク質クロマトグラフィープロセスの分離特性の推定および無菌化